Literature DB >> 26384319

Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor.

Ana Sebio1, Heinz-Josef Lenz2.   

Abstract

The Salvador-Warts-Hippo pathway controls cell fate and tissue growth. The main function of the Hippo pathway is to prevent YAP and TAZ translocation to the nucleus where they induce the transcription of genes involved in cell proliferation, survival, and stem cell maintenance. Hippo signaling is, thus, a complex tumor suppressor, and its deregulation is a key feature in many cancers. Recent mounting evidence suggests that the overexpression of Hippo components can be useful prognostic biomarkers. Moreover, Hippo signaling appears to be intimately linked to some of the most important signaling pathways involved in cancer development and progression. A better understanding of the Hippo pathway is thus essential to untangle tumor biology and to develop novel anticancer therapies. Here, we comment on the progress made in understanding Hippo signaling and its connections, and also on how new drugs modulating this pathway, such as Verteporfin and C19, are highly promising cancer therapeutics. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26384319      PMCID: PMC4644679          DOI: 10.1158/1078-0432.CCR-15-0411

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  58 in total

Review 1.  Regulation of the Hippo pathway by cell architecture and mechanical signals.

Authors:  Molly C Schroeder; Georg Halder
Journal:  Semin Cell Dev Biol       Date:  2012-06-26       Impact factor: 7.727

2.  Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2.

Authors:  Hyun-Jung Choi; Haiying Zhang; Hongryeol Park; Kyu-Sung Choi; Heon-Woo Lee; Vijayendra Agrawal; Young-Myeong Kim; Young-Guen Kwon
Journal:  Nat Commun       Date:  2015-05-12       Impact factor: 14.919

3.  Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras.

Authors:  David Matallanas; David Romano; Fahd Al-Mulla; Eric O'Neill; Waleed Al-Ali; Piero Crespo; Brendan Doyle; Colin Nixon; Owen Sansom; Matthias Drosten; Mariano Barbacid; Walter Kolch
Journal:  Mol Cell       Date:  2011-12-23       Impact factor: 17.970

4.  Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.

Authors:  Wesley M Konsavage; Sydney L Kyler; Sherri A Rennoll; Ge Jin; Gregory S Yochum
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

5.  Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.

Authors:  Yasmine Touil; Wassila Igoudjil; Matthieu Corvaisier; Anne-Frédérique Dessein; Jérôme Vandomme; Didier Monté; Laurence Stechly; Nicolas Skrypek; Carole Langlois; Georges Grard; Guillaume Millet; Emmanuelle Leteurtre; Patrick Dumont; Stéphanie Truant; François-René Pruvot; Mohamed Hebbar; Fan Fan; Lee M Ellis; Pierre Formstecher; Isabelle Van Seuningen; Christian Gespach; Renata Polakowska; Guillemette Huet
Journal:  Clin Cancer Res       Date:  2013-12-09       Impact factor: 12.531

6.  Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1.

Authors:  Run Fan; Nam-Gyun Kim; Barry M Gumbiner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

7.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

Authors:  Dawang Zhou; Claudius Conrad; Fan Xia; Ji-Sun Park; Bernhard Payer; Yi Yin; Gregory Y Lauwers; Wolfgang Thasler; Jeannie T Lee; Joseph Avruch; Nabeel Bardeesy
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

8.  TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.

Authors:  M Bartucci; R Dattilo; C Moriconi; A Pagliuca; M Mottolese; G Federici; A Di Benedetto; M Todaro; G Stassi; F Sperati; M I Amabile; E Pilozzi; M Patrizii; M Biffoni; M Maugeri-Saccà; S Piccolo; R De Maria
Journal:  Oncogene       Date:  2014-02-17       Impact factor: 9.867

9.  Hypoxic conditions differentially regulate TAZ and YAP in cancer cells.

Authors:  Libo Yan; Qingchun Cai; Yan Xu
Journal:  Arch Biochem Biophys       Date:  2014-07-29       Impact factor: 4.013

10.  Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins.

Authors:  B V V G Reddy; Kenneth D Irvine
Journal:  Dev Cell       Date:  2013-03-11       Impact factor: 12.270

View more
  26 in total

1.  Novel HMGA2-YAP1 fusion gene in aggressive angiomyxoma.

Authors:  Mee-Young Lee; Brandon da Silva; Daniel C Ramirez; Robert G Maki
Journal:  BMJ Case Rep       Date:  2019-05-28

2.  Hippo pathway regulates neural stem cell quiescence.

Authors:  Rouven Ding; Christian Berger
Journal:  Cell Cycle       Date:  2016-04-08       Impact factor: 4.534

3.  Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A.

Authors:  Madhuram Khandelwal; Vivek Anand; Sandeep Appunni; Amlesh Seth; Prabhjot Singh; Sandeep Mathur; Alpana Sharma
Journal:  Mol Cell Biochem       Date:  2018-01-24       Impact factor: 3.396

4.  miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.

Authors:  Y Guo; J Cui; Z Ji; C Cheng; K Zhang; C Zhang; M Chu; Q Zhao; Z Yu; Y Zhang; Y-X Fang; W-Q Gao; H H Zhu
Journal:  Oncogene       Date:  2017-07-24       Impact factor: 9.867

Review 5.  The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines.

Authors:  Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

Review 6.  Anti-carcinogenic effects of exercise-conditioned human serum: evidence, relevance and opportunities.

Authors:  Richard S Metcalfe; Rachael Kemp; Shane M Heffernan; Rachel Churm; Yung-Chih Chen; José S Ruffino; Gillian E Conway; Giusy Tornillo; Samuel T Orange
Journal:  Eur J Appl Physiol       Date:  2021-04-17       Impact factor: 3.078

7.  Development and function of smooth muscle cells is modulated by Hic1 in mouse testis.

Authors:  Aya Uchida; Sadman Sakib; Elodie Labit; Sepideh Abbasi; R Wilder Scott; T Michael Underhill; Jeff Biernaskie; Ina Dobrinski
Journal:  Development       Date:  2020-07-13       Impact factor: 6.862

8.  Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex.

Authors:  Honglong Wei; Fuhai Wang; Yong Wang; Tao Li; Peng Xiu; Jingtao Zhong; Xueying Sun; Jie Li
Journal:  Cancer Sci       Date:  2017-03       Impact factor: 6.716

9.  A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials.

Authors:  A Sebio; S Stintzing; V Heinemann; Y Sunakawa; W Zhang; W Ichikawa; A Tsuji; T Takahashi; A Parek; D Yang; S Cao; Y Ning; S Stremitzer; S Matsusaka; S Okazaki; A Barzi; M D Berger; H-J Lenz
Journal:  Pharmacogenomics J       Date:  2016-10-04       Impact factor: 3.550

10.  Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma.

Authors:  Xiangxiang Zhou; Na Chen; Hongzhi Xu; Xiaoming Zhou; Jianhong Wang; Xiaosheng Fang; Ya Zhang; Ying Li; Juan Yang; Xin Wang
Journal:  J Hematol Oncol       Date:  2020-06-16       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.